EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- 1 June 2008
- Vol. 26 (25) , 3153-3161
- https://doi.org/10.1016/j.vaccine.2008.03.083
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotypeProceedings of the National Academy of Sciences, 2007
- A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV CAIDS, 2007
- Characterization of a Virtually Full-Length Human Immunodeficiency Virus Type 1 Genome of a Prevalent Intersubtype (C/B′) Recombinant Strain in ChinaJournal of Virology, 2000
- Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus — poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humansVaccine, 2000
- Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate forPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 1998